Post Market TRUST - U.S.A. Study

Inclusion Criteria: * Are ≥ 18 years old and menstruating * Have symptomatic uterine fibroids * Have a uterine size ≤ 16 gestational weeks as determined by pelvic exam * Have all fibroids that are less than 10 cm in any diameter * Desire uterine conservation * Have had a normal Pap smear within the past 36 months defined as "no untreated cervical malignancy or dysplasia." * Are willing and able to comply with all study tests, procedures, and assessment tools * Are capable of providing informed consent. Exclusion Criteria: * Have contraindications for laparoscopic surgery and/or general anesthesia. * Are expected to be high risk for, or are known to have, significant intra-abdominal adhesions (defined as adhesions that would require extensive dissection to mobilize and view all surfaces of the uterus) * Patients requiring major elective concomitant procedures (e.g., hernia repair) * Are pregnant or lactating * Have taken any depot gonadotropin releasing hormone (GnRh) agonist within three months prior to the screening procedures * Have an implanted intrauterine or fallopian tube device for contraception that cannot or will not be removed at least 10 days prior to treatment * Have chronic pelvic pain known to not be due to uterine fibroids * Have known or suspected endometriosis Stage 3 or 4, adenomyosis * Have active or history of pelvic inflammatory disease * Have a history of, or evidence of, gynecologic malignancy or pre-malignancy within the past five years * Have had pelvic radiation * Have a non-uterine pelvic mass over 3 cm * Have a cervical myoma * Have one or more completely intracavitary submucous fibroids (Type 0) or only Type 0/1 submucous fibroids that are better treated via hysteroscopic methods * In the medical judgment of the investigator should not participate in the study * Are not willing to be randomized to treatment.